HomeGRAL • NASDAQ
add
Grail Inc
Nakaraang pagsara
$17.73
Sakop ng araw
$17.23 - $17.71
Sakop ng taon
$12.33 - $24.92
Market cap
590.70M USD
Average na Volume
982.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 28.65M | 38.27% |
Gastos sa pagpapatakbo | 175.74M | -12.27% |
Net na kita | -125.69M | 85.90% |
Net profit margin | -438.67 | 89.80% |
Kita sa bawat share | -3.50 | — |
EBITDA | -125.27M | 18.72% |
Aktuwal na % ng binabayarang buwis | 27.10% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 853.55M | — |
Kabuuang asset | 3.12B | — |
Kabuuang sagutin | 530.32M | — |
Kabuuang equity | 2.59B | — |
Natitirang share | 33.60M | — |
Presyo para makapag-book | 0.23 | — |
Return on assets | -12.88% | — |
Return on capital | -15.14% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -125.69M | 85.90% |
Cash mula sa mga operasyon | -104.58M | 33.60% |
Cash mula sa pag-invest | -971.00K | 68.36% |
Cash mula sa financing | 0.00 | -100.00% |
Net change in cash | -105.29M | -21.33% |
Malayang cash flow | -36.90M | — |
Tungkol
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms.
Grail was spun-out from Illumina on June 24, 2024.
Their liquid biopsy was launched in June 2021 and is called the Galleri test. Promoted as groundbreaking, the test performed poorly in testing and Grail has subsequently faced discontent and legal action from investors claiming they have been misled about the test's potential. Wikipedia
Itinatag
2015
Headquarters
Website
Mga Empleyado
1,170
